Baltimore Business Journal

The University of Maryland, Baltimore put out requests for proposals Monday for the construction of its third building in a growing biotechnology research park adjacent to its campus.

The biopark's first building and nearby parking garage opened in October 2005. Tenants in the first building include biotech and life science companies like Alba Therapeutics, a University of Maryland spinoff company, and FASgen, which was developed out of research from Johns Hopkins University.

The biopark's second building, at 801 W. Baltimore St., is slated to open this summer. The first two buildings were built and are managed by Wexford Science + Technology, a Baltimore-based real estate and development company.

Once complete, the biopark at University of Maryland could have up to 10 buildings with 1.2 million square feet of lab and office space.

In addition to the UM Biopark, a new biotechnology and life sciences office park is also under way in East Baltimore. Located near Johns Hopkins Hospital, the Life Science and Technology Park, could open its first building by May 2008. Once complete, it could include five buildings with 1.1 million square feet of lab and office space.